Research our advanced CARTO® System and non-navigational solutions for treating cardiac arrhythmias. Better tools promote better outcomes.
Discover CARTO® solutions that provide superior navigational and mapping features to help you treat the patterns that matter for your patients. Diagnostic, mapping and therapeutic tools designed to help you see more, know more and do more.
Explore our non-navigational solutions developed to give you optimal control, allowing for more confident access and validation when diagnosing and treating arrhythmias.
Different arrhythmias require different treatments. Browse our products by treatment type:
© Biosense Webster, Inc. 2009-2015. All Rights Reserved.
This site is published by Biosense Webster, Inc. which is solely responsible for its content.
This site is intended for Healthcare Professionals residing in the United States.
Click here for our California Health Care Compliance Information and AdvaMed Code.
In the U.S., THERMOCOOL® Navigation Catheters are approved for drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with CARTO® Systems (excluding NAVISTAR® RMT THERMOCOOL® Catheter). Biosense Webster THERMOCOOL® Catheters are indicated for Type I Atrial Flutter in patients 18 years of age or older.
Always verify catheter tip location using fluoroscopy or IC signals and consult the CARTO® System User Guide regarding recommendations for fluoroscopy use.
Bertaglia E, Bella PD, Tondo C, Proclemer A, Bottoni N, De Ponti R, et al. Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CARTOMERGE® Module Italian Registry. Europace 2009;11:1004-1010.
THERMOCOOL® Navigation Catheters are approved for recurrent drug/device refractory sustained monomorphic ventricular tachycardia (VT) due to prior myocardial infarction (MI) in adults (excluding THERMOCOOL® SF Catheters). The clinical significance of utilizing the PASO™ Module to help pace mapping for catheter ablation of ventricular arrhythmias has not been demonstrated by clinical investigations.
The NAVISTAR® THERMOCOOL® and EZ STEER® THERMOCOOL® NAV Catheters are FDA approved for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible three-dimensional electroanatomic mapping systems. Catheter ablation for AF may not be an option for you if you have any of the following conditions: certain recent heart surgery; prosthetic valves; active systemic infection; certain cancers; intracardiac thrombus, or an interatrial baffle or patch. Consult your physician to find out if catheter ablation is right for you. Known complications of catheter ablation include the following: bleeding, swelling or bruising at the catheter insertion site, and infection. More serious complications are rare, which can include damage to the heart or blood vessels; blood clots (which may lead to stroke); heart attack, or death.
Third party trademarks used herein are trademarks of their respective owners.
This site last updated on December 4, 2014.